Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen- resistant growth of MCF-7 breast cancer cells

Cancer Research

Volumn 58, Issue 2, 1998, Pages 352-361

  Zhang, Lurong ^a,b   Kharbanda, Samir ^a   Hanfelt, John ^a,b   Kern, Francis G ^a,b,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANTIESTROGEN; ESTRADIOL; ESTROGEN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR; TAMOXIFEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; GROWTH REGULATION; HORMONAL REGULATION; HORMONE RESISTANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; AUTOCRINE COMMUNICATION; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; FIBROBLAST GROWTH FACTOR 1; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PARACRINE COMMUNICATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA, MESSENGER; TAMOXIFEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031974288     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Smith, J., Yelland, A., Baillie, R., and Coombes, R. C. Acidic and basic fibroblast growth factors in human breast tissue. Eur. J. Cancer. 30A: 496-503, 1994.
2. Bansal, G. S., Yiangou, C., Coope, R. C., Gomm, J. J., Luqmani, Y. A., Coombes, R. C., and Johnston, C. L. Expression of fibroblast growth factor 1 is lower in breast cancer than in normal human breast. Br. J. Cancer, 72: 1420-1426, 1995.
3. Penault-Llorca, F., Bertucci, F., Adelaide, J., Parc, P., Coulier, F., Jacquemier, J., Birnbaum, D., and deLapeyriere, O. Expression of FGF and FGF receptor genes in human breast cancer. Int. J. Cancer, 61: 170-176, 1995.
4. Anandappa, S. Y., Winstanley, J. H., Leinster, S., Green, B., Rudland, P. S., and Barraclough, R. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer, 69: 772-776, 1994.
5. Ding, I. Y. F., McLeskey, S. W., Chang, K., Fu, Y. M., Acol, J. C., Shou, M. T., Alitalo, K., and Kern, F. G. Expression of fibroblast growth factors (FGFS) and receptors (FGFRS) in human breast carcinomas. Proc. Am. Assoc. Cancer Res., 33: 269, 1992.
6. Zhang, L., Kharbanda, S., Chen, D., Bullocks, J., Miller, D. L., Ding, I. Y. F., Hanfelt, J., McLeskey, S. W., and Kern, F. G. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice. Oncogene, 15: 2093-2108, 1997.
7. McLeskey, S. W., Kurebayashi, J., Honig, S. F., Zwiebel, J., Lippman, M. E., Dickson, R. B., and Kern, F. G. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res., 53: 2168-2177, 1993.
8. McLeskey, S. W., Ding, I. Y. F., Lippman, M. E., and Kern, F. G. MDA-MB-134 breast carcinoma cells overexpress FGF receptors and are growth-inhibited by FGF ligands. Cancer Res., 54: 523-530, 1994.
9. Lehtola, L., Partanen, J., Sistonen, L., Korhonen, J., Wärri, A., Härkönen, P., Clarke, R., and Alitalo, K. Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast cancer cells. Int. J. Cancer, 50: 598-603, 1992.
10. Fenig, E., Wieder, R., Paglin, S., Wang, H., Resaud, R., Haimovitz-Friedman, A., Fuks, Z., and Yahalom, J. Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. Clin. Cancer Res., 3: 135-142, 1997.
11. Wellstein, A., Zugmaier, G., Califano, J. A., III, Kern, F., Paik, S., and Lippman, M. E. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J. Natl. Cancer Inst., 83: 716-720, 1991.
12. McLeskey, S. W., Zhang, L., Kharbanda, S., Liu, Y., Trock, B. J., Gottardis, M. M., Lippman, M. E., and Kern, F. G. Effects of AGM-1470 and pentosan polysulfate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells. Br. J. Cancer, 73: 1053-1062, 1996.
13. Givol, D., and Yayon, A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J., 6: 3362-3369, 1992.
14. Bellot, F., Crumley, G., Kaplow, J. M., Schlessinger, J., Jaye, M., and Dionne, C. A. Ligand-induced transphosphorylation between different FGF receptors. EMBO J., 10: 2849-2854, 1991.
15. Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., and Lax, I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell, 79: 1015-1024, 1994.
16. Ueno, H., Gunn, M., Dell, K., Tseng, A., Jr., and Williams, L. A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J. Biol. Chem., 267: 1470-1476, 1992.
17. Amaya, E., Musci, T. J., and Kirschner, M. W. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell, 66: 257-270, 1991.
18. Li, Y., Basilico, C., and Mansukhani, A. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol. Cell. Biol., 14: 7660-7669, 1994.
19. Johnson, D. E., Lee, P. L., Lu, J., and Williams, L. T. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol., 10: 4728-4736, 1990.
20. Miller, D. L., El-Ashry, D., Cheville, A. L., Liu, Y., McLeskey, S. W., and Kern, F. G. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ., 5: 1263-1274, 1994.
21. Hartman, S. C., and Mulligan, R. C. Two dominant-acting markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. USA, 85: 8047-8051, 1988.
22. Kurebayashi, J., McLeskey, S. W., Johnson, M. D., Lippman, M. E., Dickson, R. B., and Kern, F. G. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res., 53: 2178-2187, 1993.
23. Chen, C., and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7: 2745-2752, 1987.
24. Werner, S., Duan, D. R., DeVries, C., Peters, K. G., Johnson, D. E., and Williams, L. T. Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol. Cell. Biol., 12: 82-88, 1992.
25. Kan, M., Shi, E. G., and McKeehan, W. L. Identification and assay of fibroblast growth factor receptors. Methods Enzymol., 198: 158-171, 1991.
26. Dionne, C. A., Crumley, G., Bellot, F., Kaplow, J. M., Searfoss, G., Ruta, M., Burgess, W. H., Jaye, M., and Schlessinger, J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J., 9: 2685-2692, 1990.
27. Heitjan, D. F., Manni, A., and Santen, R. J. Statistical analysis of in vivo tumor growth measurements. Cancer Res., 53: 6042-6050, 1993.
28. Shi, E., Kan, M., Xu, J., Wang, F., Hou, J., and McKeehan, W. L. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol. Cell. Biol., 13: 3907-3918, 1993.
29. Eisemann, A., Ahn, J. A., Graziani, G., Tronick, S. R., and Ron, D. Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene, 6: 1195-1202, 1991.
30. Hou, J., Kan, M., McKeehan, K., McBride, G., Adams, P., and McKeehan, W. L. Fibroblast growth factors receptors from liver vary in three structural domains. Science (Washington DC), 251: 665-668, 1991.
31. 1 checkpoint. Mol. Cell. Biol., 16: 6917-6925, 1996.
32. Gospodarowicz, D., Ferrara, N., Schweigerer, L., and Neufeld, G. Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev., 8: 95-114, 1987.
33. Zhang, H., Craft, P., Scott, P. A. E., Ziche, M., Weich, H. A., Harris, A. L., and Bicknell, R. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl. Cancer Inst., 87: 213-219, 1995.
34. Macaulay, V. M., Fox, S. B., Zhang, H., Whitehouse, R. M., Leek, R. D., Gatter, K. C., Bicknell, R., and Harris, A. L. Breast cancer angiogenesis and tamoxifen resistance. Endocr.-Relat. Cancer, 2: 97-103, 1997.
35. Bullocks, J., Zhang, L., Ding, I. Y. F., McLeskey, S. W., Tobias, C. A., Miller, D. L., and Kern, F. G. Overexpression of vascular endothelial growth factor (VEGF) in MCF-7 breast carcinoma cells facilitates growth in tamoxifen-treated nude mice and tumor cell dissemination. Proc. Am. Assoc. Cancer Res., 38: 525, 1997.
36. Holmgren, L., O'Reilly, M. S., and Folkman, J Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
37. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
38. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
39. Lu, C., and Tanigawa, N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res., 57: 221-224, 1997.
40. Jordan, V. C., Gottardis, M. M., Robinson, S. P., and Friedl, A. Immune-deficient animals to study *hormone-dependent* breast and endometrial cancer. J. Steroid Biochem., 34: 169-176, 1989.
41. Gagliardi, A. R., Hennig, B., and Collins, D. C. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res., 16: 1101-1106, 1996.